Valensa Using Superba Krill Oil

EUSTIS, Fla.Valensa International signed an exclusive, long-term global supply ingredient with Olso, Norway-based Aker BioMarine; Valensa will incorporate Superba Krill Oil in its proprietary joint health and eye health formulations. The companies will also jointly perform clinical studies to document the benefits of Superba Krill oil in Valensas patented and patent-pending products.

 We are very excited about the opportunity to work with Valensa, and this agreement marks the entry of Superba Krill Oil into the joint health market, the largest category of dietary supplements, representing $3.4 billion in the United States alone, said Matts Johansen, Aker BioMarines executive vice president of sales and marketing. As such, joint health is close to 300 percent larger than the cardiovascular health category and obviously an interesting market for us to enter into.

Valensa will use Superba Krill Oil in its condition-specific dietary supplement formulas in conjunction with several of its own proprietary ingredients, such as Zanthin® Natural Astaxanthin. In a statement issued by Valensa, CEO Rudi E. Moerck, said, The increased potency of formulas containing krill [that allow] formulators and marketers to reduce the size of their softgels and reduce the pill burden on people is one of the key reasons for using Superba Krill Oil in Valensas proprietary formulations.